Dr. Thummala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7445 Peak Dr
Las Vegas, NV 89128Phone+1 702-952-2140Fax+1 702-952-2147
Education & Training
University of RochesterFellowship, Hematology and Medical Oncology, 1999 - 2002
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
Rangaraya Medical College NTRClass of 1993
Certifications & Licensure
TX State Medical License 2003 - 2026
NV State Medical License 2005 - 2025
WV State Medical License 2002 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 16 citationsTrilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.Antoinette R Tan, Gail S Wright, Anu R Thummala, Michael A Danso, Lazar Popovic
Clinical Cancer Research. 2022-02-15 - 87 citationsOverall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- ad...Richard S. Finn, Katalin Boér, Igor Bondarenko, Ravindranath Patel, Tamás Pintér
Breast Cancer Research and Treatment. 2020-07-18 - 70 citationsTrilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trialAntoinette R. Tan, Gail S. Wright, Anu Thummala, Michael A. Danso, Lazar Popovic
The Lancet. Oncology. 2019-11-01
Other Languages
- Hindi, Telugu, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
